The present disclosure in some embodiments relates to an ultrasonic transducer.
The statements in this section merely provide background information related to the present disclosure and do not necessarily constitute prior art.
Extracorporeal shockwave therapy (ESWT) is a method of treating an affected area by irradiating therapeutic ultrasonic waves on an object to be examined.
Commonly-used ESWT apparatuses include an ultrasonic transducer and use a method of irradiating therapeutic ultrasonic waves from the ultrasonic transducer to an affected area.
In general, an ultrasonic transducer includes piezoelectric elements for irradiating therapeutic ultrasonic waves on the object.
At this time, for the treatment of the object, the ultrasonic transducer needs to have the piezoelectric elements in an arrangement that can effectively deliver the therapeutic ultrasound irradiation to the affected area.
In addition, to properly arrange the piezoelectric elements in a typical ultrasonic transducer so that the therapeutic ultrasonic waves can be efficiently delivered to the affected area of the object, the ceramic material for the piezoelectric elements needs to be processed into an appropriate shape.
As shown in
The piezoelectric elements 11 irradiate the therapeutic ultrasonic waves toward the affected area of the object.
The plurality of piezoelectric elements 11 are configured in circumferential shapes, that is, ring shapes, each having a different diameter, as shown in
Here, the therapeutic ultrasonic wave irradiated from each of the piezoelectric elements 11 may be irradiated intensively to the affected area of the object by arranging a separate acoustic lens (not shown).
Alternatively, adjustment of the amplitude or phase of the driving signal inputted to a separate piezoelectric element 11 can intensively irradiate the therapeutic ultrasonic wave to the affected area of the object.
On the other hand, if the innermost ring-shaped piezoelectric element 11 of the plurality of piezoelectric elements 11 has an inner diameter of R1-in and an outer diameter of R1-out, then the second, larger diameter ring-shaped piezoelectric element 11 needs to be designed to have an inner diameter of R2-in which is equal to or slightly larger than R1-out.
Similarly, the third, larger diameter ring-shaped piezoelectric element 11 needs to be designed to have an inner diameter of R3-in which is equal to or slightly larger than R2-out.
Such an arrangement of the piezoelectric elements 11 in differently sized ring shapes as described above is to cause therapeutic ultrasonic waves emitted from the piezoelectric elements 11 to be effectively focused on the affected area of the object.
At this time, the piezoelectric elements 11 are manufactured by processing ceramic materials such as barium titanate (BaTiO3), lead titanate (PbTiO3), and lead zirconate system (PbZrO3) by using a microelectromechanical systems (MEMS) technology.
In addition, there is a need for a process of attaching the piezoelectric elements 11 each having a differently sized ring shape on the substrate through a thermal pressing method or an ultrasonic bonding.
To manufacture the piezoelectric elements 11 made of ceramic materials to have different sizes in this way requires a special manufacturing facility capable of manufacturing respectively different diameters of ring-shaped piezoelectric elements 11 to go through a complicated manufacturing process.
Therefore, the ring-annular array type ultrasonic transducer 1 consumes a lot of effort to manufacture and increases the processing cost.
On the other hand, with a matrix array or a circular array type ultrasonic transducer other than the ring-annular array type shown in
Accordingly, there is a need to provide a proper arrangement of piezoelectric element arrays, which is easy to manufacture and has an appropriate therapeutic effect in the treatment of the subject.
Therefore, the present disclosure seeks to provide an ultrasonic transducer having a simple configuration while having an excellent therapeutic effect due to the effective focusing of therapeutic ultrasonic waves on a target region.
Further, the present disclosure aims to provide an ultrasonic transducer that saves time and cost for processing or manufacturing.
According to some embodiments of the present disclosure, an ultrasonic transducer is provided, including a housing, a base disposed on a front surface of the housing, and multiple linear arrays each arranged in a radial direction on the base, extending from a central region of the base, and configured to irradiate a therapeutic ultrasonic wave, the linear arrays each comprising a plurality of piezoelectric elements which are linear elements extending side by side with each other in the radial direction.
Hereinafter, at least one embodiment of the present disclosure will be described in detail with reference to the accompanying drawings. In the following description, like reference numerals would rather designate like elements although the elements are shown in different drawings. Further, in the following description of the at least one embodiment, a detailed description of known functions and configurations incorporated herein will be omitted for the purpose of clarity and for brevity.
Additionally, various terms such as first, second, i), ii), (a), (b), etc., are used solely to differentiate one component from the other but not to imply or suggest the substances, order, or sequence of the components. Throughout this specification, when a part “includes” or “comprises” a component, the part is meant to further include other components, not excluding thereof unless there is a particular description contrary thereto.
As shown in
The housing 110 provides a space for placement of the base 120, the linear arrays 130, the imaging probe 140, and others.
Of the housing 110, an area in which the base 120, the linear arrays 130, and the imaging probe 140 are placed may be referred to as a front portion which may then be peripherally bent forward into an L or “¬” shape so that the front portion of the housing 110 has a space for the base 120.
In addition, the front portion of the housing 110 may be formed in an exemplary cylindrical or polygonal column shape. Disposed on the front portion of the housing 110 is the base 120 having an upper surface, on which the linear arrays 130 are disposed.
In addition, disposed on the housing 110 centrally and forwardly thereof is the imaging probe 140.
On the other hand, the housing 110 shown in
In addition, each linear array 130 extends to a position spaced 5 mm from the outermost of the housing 110, and two diagonally opposite linear arrays 130 have their distal ends separated by a distance D2 of 100 mm.
The base 120 provides a space for the linear arrays 130 to be disposed. The linear array 130 are disposed on the front surface of the base 120 which may serve as a backing panel supporting the linear arrays 130.
As shown in
Disposed centrally of the base 120 is the imaging probe 140, and the linear arrays 130 are disposed circumferentially of a region in which the imaging probe 140 is disposed. In the ultrasonic transducer 100 shown in
The linear array 130 has its piezoelectric elements that generate vibrations which in turn generate therapeutic ultrasonic waves that are irradiated toward the object.
The linear array 130 refers to a linear array type in which rectilinear piezoelectric elements having similar lengths and widths are arranged side by side and adjacent to each other. The linear array 130 includes long sides formed to be relatively elongated along the longitudinal direction thereof, and short sides formed to be relatively short along the latitudinal or widthwise direction thereof.
Multiples of the linear array 130 are arranged over the front surface of the base 120. The multiple linear arrays 130 are disposed adjacent to the central region of the front surface of the base 120, and the linear arrays 130 are radially disposed around the central region of the front surface of the base 120.
Specifically, a radial direction of the base 120 may refer to an arbitrary direction from the center point of the front surface of the base 120 toward the outer edge of the front surface of the base 120, wherein the linear array 130 is arranged so that its longitudinal axis lies on the radial direction of the base 120.
At this time, the long sides of the linear array 130 are disposed in parallel to the radial direction of the base 120, and the short sides of the linear array 130 are vertically disposed to the radial direction of the base 120.
On the other hand, each linear array 130 is composed of a plurality of piezoelectric elements, and due to such a configuration, the ultrasonic transducer 100 according to at least one embodiment of the present disclosure may be made advantageously through a simple manufacturing process and uncomplicated facilities for manufacturing as will be described in detail below.
The imaging probe 140 serves to generate information about the ultrasound image of the object and to transfer the same information to an unshown display unit. Although not shown, the imaging probe 140 includes an imaging ultrasound transmitter and an imaging ultrasound receiver.
The imaging ultrasound transmitter irradiates imaging ultrasonic waves toward an object. The imaging ultrasound receiver receives an echo signal of the imaging ultrasonic waves reflected by the object.
The echo signal received by the imaging ultrasound receiver is converted into an image signal by an unshown signal processing unit, and the image signal is transmitted to the display unit for outputting the ultrasonic image of the object.
The acoustic lens 150 concentrates therapeutic ultrasonic waves into a target region.
The acoustic lens 150 is disposed forwardly of the base 120 and the plurality of linear arrays 130, and the therapeutic ultrasound component irradiated from the linear arrays 130 passes through the acoustic lens 150 to be focused on one area of the object.
The acoustic lens 150 provided as described above can efficiently focus the therapeutic ultrasonic waves, resulting in an enhanced curative effect.
On the other hand, at least one embodiment of the present disclosure illustrates the configuration having the acoustic lens 150 for focusing the therapeutic ultrasonic waves, although the one embodiment further includes a configuration for adjusting the focusing position of the therapeutic ultrasonic waves by using a beamforming technique.
In particular, the one embodiment of the present disclosure may still include a configuration in which the focusing position of the therapeutic ultrasonic waves is adjusted by adjusting the amplitude or phase of the driving signal inputted to the piezoelectric elements of the linear array 130. In this case, the acoustic lens 150 is not necessarily provided for concentrating therapeutic ultrasonic waves.
On the other hand, since each therapeutic ultrasonic wave needs to be focused on a set focal region P1, the acoustic lens 150 may be configured so that the degree of refraction of each therapeutic ultrasound component is different.
Meanwhile, the acoustic lens 150 may have a curvature R1 of, for example, 90 mmR, although and the acoustic lens 150 may be designed to have a different, appropriate curvature.
The gel pad 160 is disposed on the front of the acoustic lens 150 to facilitate the delivery of the therapeutic ultrasonic waves. The therapeutic ultrasound waves irradiated from the linear array 130 are focused by the acoustic lens 150 and passes through the gel pad 160 to be irradiated through the object.
The gel pad 160 may be internally filled with fluid and may serve to reduce attenuation, scattering, and the like of therapeutic ultrasonic waves irradiated from the linear array 130.
In addition, once filled with a fluid, the gel pad 160 may also serve to cool the heat generated by ultrasonic waves.
The thickness of the gel pad 160 from the base 120 may be about 30 mm, although the thickness thereof may be designed differently.
In addition, the ultrasonic transducer 100 according to at least one embodiment of the present disclosure may include unshown signal transmission/reception lines inside the housing 110 or in an unshown controller.
In addition, the ultrasonic transducer 100 according to at least one embodiment of the present disclosure may include features such as an unshown power button and an operation input button capable of controlling its operation, and it may be linked to a separate control device. However, those features are not to be focused on in the configuration of the present disclosure, and a detailed description thereof will be omitted.
As showing in
The ultrasonic transducer 100 according to at least one embodiment of the present disclosure has a distinctive type in which multiple uniformly rectilinear piezoelectric elements are arranged adjacent to each other into a linear array type. Accordingly, each linear array 130 has a rectangular shape.
The at least one embodiment of the present disclosure illustrates a case where the linear array 130 has an aspect ratio of short side to long side of about 16 mm to 34 mm. The at least one embodiment may be modified to have other aspect ratios of the linear array 130.
At this time, in consideration of the treatment efficiency by the degree of focusing the therapeutic ultrasonic waves when the ultrasonic transducer 100 is operated and of the arrangement and shape of the base 120 and other components, the aspect ratio of short side to long side is preferably 1:2 to 1:4 or less.
The linear arrays 130 constituting the first aspect of ultrasonic transducer 100 are disposed interspaced from one another at a predetermined angle, respectively. At this time, the angle at which each linear array 130 is spaced from the adjacent one may be about 90 degrees.
Accordingly, the linear arrays 130 are disposed to have a length in the upper, lower, left and right directions surrounding the center of the base 120, respectively, and the respective linear arrays 130 are formed to have the same shape.
Therefore, the respective linear arrays 130 have a point-symmetrical arrangement relative to the center of the base 120.
The respective linear arrays 130 may be fabricated to have a uniform shape and size. Therefore, in manufacturing the ultrasonic transducer 100, there is no need for a manufacturing facility or the like for separately manufacturing each array or each piezoelectric element.
Accordingly, the ultrasonic transducer 100 according to at least one embodiment of the present disclosure takes a simple process of manufacturing the respective linear arrays 130 as will be detailed below, and it obviates the need for such a complicated process and a manufacturing facility as in the comparative example described above to manufacture the linear arrays 130.
On the other hand, the present applicant was able to confirm that the first aspect of the ultrasonic transducer 100 according to the at least one embodiment has a significant efficiency in terms of its therapeutic effect when compared to the aforementioned comparative example.
Further, despite allocating a narrower area to its linear arrays 130 than the annular array type ultrasonic transducer 1 does, the ultrasonic transducer 100 according to the at least one embodiment was confirmed to have the curative effect similar to that of the annular array type ultrasonic transducer 1.
This provides an advantage that the ultrasonic transducer 100 according to the at least one embodiment can be manufactured more simply, consuming less material than the comparative example as well as perform an effective treatment on a subject.
The second aspect of the at least one embodiment of the present disclosure, as in the case of the first aspect, a plurality of line-type linear arrays 130 are disposed on the base 120. Specifically, the linear arrays 130 are disposed adjacent to the central region of the base 120 so that the linear arrays 130 have their longitudinal axes extend in the radial direction of the base 120.
However, different from the first aspect, the second aspect has the linear arrays 130 spaced apart from each other by 45 degrees. Therefore, in contrast to the first aspect wherein a high-intensity focused ultrasound (HIFU) transducer unit is composed of a total of four linear arrays 130, the second aspect provides a HIFU transducer unit composed of a total of eight linear arrays 130.
In this way, the second aspect doubles the number of linear arrays 130 of the first aspect to minimize the difference in the area occupied by the linear arrays 130 on the base 120 when compared with the annular array type transducer.
This can increase the area of the irradiation source for irradiating the therapeutic ultrasonic waves, thereby increasing the ultrasound focusing and curative effect to a level almost the same as the annular array type transducer.
As shown in
At this time, the piezoelectric elements may be manufactured using a piezoelectric material such as lead zirconate titanate (PZT), polyvinylidene fluoride (PVDF), lead magnesium niobate (PMN), and they may be electrically connected to an unshown printed circuit board wherein the driving signal establishes the piezoelectric effect for generating therapeutic ultrasonic waves.
At this time, the plurality of piezoelectric elements are each made in a linear form, and each piezoelectric element may have the same shape and size.
Therefore, during the manufacture of the linear array 130 in the at least one embodiment, the multiple piezoelectric elements may be designed to undergo the same fabrication process.
During manufacture, different from the annular array type transducer which involves fabricating and placing individual devices having different diameters, the linear array 130 in the at least one embodiment obviates the need for complicated manufacturing equipment and manufacturing processes.
Specifically,
The ultrasonic transducer 600 according to the another embodiment includes the configuration of the ultrasonic transducer 100 according to the at least one embodiment as long as they are not contrary to each other.
However, different from the ultrasonic transducer 100 according to the at least one embodiment, the ultrasonic transducer 600 according to the another embodiment has linear arrays 630 disposed on a curved surface.
As shown in
At this time, the central region of the base 620 may be formed to be constant in, for example, its thickness and may be provided with an imaging probe 640. Meanwhile, in the another embodiment, the central portion of the base 620 has a height H1 of about 12.4 mm.
The front portion of the base 620 needs to be curved toward the area to be irradiated with therapeutic ultrasonic waves, for which the thickness of the base 620 gradually increases as it deviates from the central region of the base 620. For example, the base 620 has a height H2 of about 30 mm at the outermost portion thereof.
At this time, the curvature of the front portion of the base 620 may be determined by roughly considering the distance from the base 620 to the focal position P2 of the therapeutic ultrasonic waves, and illustratively, the front portion of the base 620 has a curvature R2 of 90 mmR.
In addition, conforming to such curved configuration of the front portion of the base 620, the respective piezoelectric elements lie flush with the same curvature surface of the base 620. Accordingly, the respective linear arrays 630 are formed on the same curvature surface.
This can increase the efficiency of focusing the therapeutic ultrasonic waves irradiated from the respective piezoelectric elements into the single area of the object.
As described above, the another embodiment of the present disclosure, which has the respective piezoelectric elements formed on the curvature surface, can have a high focusing effect of therapeutic ultrasonic waves even without the acoustic lens 150 (see
Accordingly, the ultrasonic transducer 600 according to the another embodiment can be manufactured save the process of manufacturing and attaching the acoustic lens 150 (see
At this time, the ultrasonic transducer 100 was tested using a configuration in which eight linear arrays 130 are disposed on the base, and detailed specifications of the ultrasonic transducer 100 are as described above.
Here,
In addition, the z-axis direction signifies the depth direction of the object, and the x-axis and y-axis directions signify the horizontal axis direction and the vertical axis direction perpendicular to the horizontal axis direction respectively at the same depth in the object.
On the other hand, the test was conducted by providing the therapeutic ultrasonic wave with a frequency of 1.5 MHz, and the dynamic range (DR) was set to be 60 dB. These settings apply to all of the following processes.
In addition, depending on the intensity of the therapeutic ultrasonic wave in the subject, the region with the strongest therapeutic ultrasonic wave was arranged to be displayed in red, and the region that has the weakest therapeutic ultrasonic wave was displayed in blue.
First, the lower-left graph of
The upper left graph of
In addition, as shown in the right graph of
Different focal positions of the therapeutic ultrasonic waves from that of
In
Specifically,
The performance test was performed using the typical transducer 1, as shown in
A comparison between
In other words,
This signifies that for the smaller footprint of the linear transducer arrays 130 of the ultrasonic transducer 100 than that of the ring-annular arrays of the ultrasonic transducer 1, the ultrasonic transducer 100 yet provides the focus intensity and strength of the therapeutic ultrasonic waves as good as that of the ultrasound transducer 1 shown in
Therefore, it can be seen that the ultrasonic transducer 100 of the present disclosure has a superior curative effect while being simple to manufacture compared to the prior art transducer 1.
The following will concentrate on differences between the yet another embodiment shown in
As shown in
Accordingly, in the yet another embodiment of
Referring to
As shown, the linear array 930 illustrated in
Referring back to
For example, as illustrated in
In addition, as illustrated in
At this time, ultrasound collection surface CA1 of
In particular,
As shown in
As described above, since the ultrasonic transducers 100, 600 according to the respective embodiments of the present disclosure are manufactured by using the line-type linear arrays 130, 630, they are manufactured through simplified manufacturing process by advantageously utilizing simplified manufacturing equipment, as compared to using other types of arrays.
In addition, the ultrasonic transducers 100, 600 according to the respective embodiments of the present disclosure have the above manufacturing advantages and yet have excellent therapeutic effects as with the prior art ultrasonic transducers.
Although exemplary embodiments of the present disclosure have been described for illustrative purposes, those skilled in the art will appreciate that various modifications, additions, and substitutions are possible, without departing from the idea and scope of the claimed invention. Therefore, exemplary embodiments of the present disclosure have been described for the sake of brevity and clarity. The scope of the technical idea of the present embodiments is not limited by the illustrations. Accordingly, one of ordinary skill would understand the scope of the claimed invention is not to be limited by the above explicitly described embodiments but by the claims and equivalents thereof.
Number | Date | Country | Kind |
---|---|---|---|
10-2018-0140429 | Nov 2018 | KR | national |
10-2019-0009447 | Jan 2019 | KR | national |
Filing Document | Filing Date | Country | Kind |
---|---|---|---|
PCT/KR2019/015629 | 11/15/2019 | WO | 00 |